Rajagopal G

Ishaan Khanna

Ishaan brings with him nearly 2 decades of experience across healthcare where he has established organizations from the ground up and scaled them into profitable business models. In his last stint he was associated with Neuberg Diagnostics, one of India's leading diagnostic service providers, with its presence across India, UAE, South Africa and USA. His earlier tenure was with Redcliffe Labs, where he focused on key strategic areas. He played a vital role in setting up specialized testing labs and expansion of regional labs and corporate businesses, which included pathology and radiology. Prior to joining Redcliffe Labs, he was working with Lifecell International as its Chief Executive Officer where he made significant contributions to scale up the business. 

Some of his notable achievements across his professional career include launching the community cord blood banking model, which was recognized and endorsed by all medical bodies, establishing the diagnostics business in Lifecell in 2013 and augmenting it to be the top mother and child diagnostic player in the country. He upscaled the business to 6 regional labs pan India and expanded from 10 tests to a 1000 test portfolio, all this while developing & launching industry-first programmes and technological solutions namely Reflex NIPT markers, QFPCR, rapid exomes, and 'Babyshield' newborn screening program. He led 4 lab acquisitions across Chennai, Pune, and Kolkata to support inorganic growth and secured 2 rounds of funding – the most recent being the USD 30 million round from Orbimed in 2021.

He holds a dual Master’s degree in Biotechnology and Enterprise from the University of Manchester. Ishaan associates himself with social health causes, enjoys traveling and has a soft spot for animals. He has also launched multiple social campaigns – the most recent being 'Hope is Life' which received many awards and accolades.

On the personal front, Ishaan is married to Ruhi who holds an MBA in Finance and is currently pursuing Investing and Trading in the stock market. She is a food enthusiast and practices meditation. They have a 5 year old son Ruhaan, who is fond of solving maths puzzles and playing chess. 

Karthik Narayanaswamy

Karthik Narayanaswamy joined Novo Holdings in January 2025 as Partner and Head of India, bringing over 20 years of experience in private equity investing, strategy consulting, and operations. 
 
Before joining Novo Holdings, Karthik was the Co-founder and Partner at SeaLink Capital Partners, a mid-market private equity firm focused on India, where he led the firm’s healthcare investments. Prior to that, he served as a Principal at KKR Capstone, where he oversaw due diligence and drove operational improvements across KKR's investments in India. 

Karthik’s earlier career includes his time at Bain & Company, where he was a founding member of the India office. During his tenure, he specialized in private equity due diligence and performance improvement. He also gained investment experience at Goldman Sachs Investment Partners and began his career at Capital One Financial in Richmond, Virginia. 

Karthik holds a Bachelor of Technology in Computer Science and Engineering from the Indian Institute of Technology (IIT) Bombay.

Dr. Raajiv Singhal

Dr. Sameer Kulkarni

Dr. Sameer Kulkarni is a distinguished healthcare leader with over 18 years of diverse experience in the hospital industry across North, Central, West and South India. He currently serves as the Chief Executive Officer at Dr. L H Hiranandani Hospital, leading the institution in delivering excellence in healthcare services. Prior to this role, Dr. Kulkarni was the Regional Director at Paras Healthcare Pvt. Ltd., where he managed an impressive portfolio of five super-specialty hospitals, overseeing 1,400+ beds, 500+ doctors, 2,500+ employees and driving a P&L of over INR 850 crore in annual revenue.

Dr. Kulkarni is an exceptional academic achiever. He holds an MBBS degree from B J Medical College, Pune, ranked among the top 10 medical colleges in India. He also holds an MBA from Case Western Reserve University, Cleveland, USA, one of the top 50 business schools in the United States, where he graduated as a university topper with a GPA of 4.0/4.0.

A dynamic and visionary leader, Dr. Sameer Kulkarni is committed to elevating the standards of healthcare delivery and driving innovation in the industry.

Dr. Karthik Narayan R

Dr Karthik has authored numerous high-impact research papers in leading international journals, including publications with the American Geriatric Society and the European Association of Palliative Care.

Sidharth Srinivasan

Sidharth Srinivasan is the CEO of Lupin Digital Health (LDH), India’s leading Digital Therapeutics company for Cardio-Metabolic care. LDH powers LYFE and VITALYFE, two clinically validated platforms adopted by hospitals, insurers, and thousands of patients across the country. 

His work focuses on building evidence-based, AI-enabled care models that improve adherence, reduce risk, and make continuous cardiac care accessible at scale. Known for his clarity of thought, operational depth, and patient-centred design ethos, Sidharth brings a grounded, data-driven perspective on how India can close its clinical, behavioural, and affordability gaps through intelligent technology-led care. At LDH, Sidharth leads a team of specialists in technology, data science, and healthcare. 

Prior to LDH, Sidharth worked with the Tata Group in leadership positions as part of the Tata Administrative Service (TAS). His forte is scaling consumer-facing business using technology.

Vikram Vuppala

Vishal Bali

Vishal Bali stands among Asia’s most influential healthcare leaders — a visionary who has redefined how healthcare is delivered, scaled, and humanised across emerging and developed markets. Over a career spanning more than three and a half decades, he has built and led billion-dollar healthcare delivery organisations across 12 countries, pioneering models that integrate scale with purpose.

As Executive Chairman of Asia Healthcare Holdings (AHH) and Senior Advisor to TPG Growth, Vishal leads a first-of-its-kind, single-speciality healthcare platform backed by global investors GIC and TPG Growth. Under his leadership, AHH has become synonymous with transformative growth and innovation, creating category leaders across fertility, oncology, women’s health, mother-and-child care and urology & nephrology care. His work embodies a deep belief that the future of healthcare lies in combining specialisation, technology, and compassionate access at scale.

Previously, he served as the Global CEO of Fortis Healthcare and the CEO & Managing Director of Wockhardt Hospitals, where he spearheaded expansion, integration, and innovation across some of India’s most respected healthcare brands.

Vishal’s influence extends well beyond the corporate sphere. He sits on the boards of leading global healthcare organisations and has served as a member of the Strategic Initiatives Group of the Joint Commission International (USA) and the Global Agenda Council on Healthcare of the World Economic Forum. His leadership journey has been featured as a case study at Harvard Business School, underscoring his impact on global healthcare delivery models.

Beyond the boardroom, Vishal’s commitment to social equity finds expression in his work with the Neonates Foundation of India, which provides life-saving neonatal care to newborns from underprivileged families.

A sought-after global speaker and industry voice, Vishal continues to champion the transformation of healthcare through innovation, policy reform, and human-centred leadership—building systems that deliver both clinical excellence and compassionate care.

Dr. Anand K.

Anand is the Managing Director & CEO of Agilus Diagnostics, India’s leading diagnostic chain that is spread across 1000+ Cities, 30 States and Union Territories with a network of 410+ Laboratories and 4000+ customer touch points. He has over 25 years of robust work experience in the healthcare industry specialising in Diagnostics and Laboratory services in India, South Asia, Africa and Middle East.

He comes with deep subject knowledge of diagnostics, combined with strong business acumen that enables him to identify business drivers, understand complex issues, take affirmative actions and drive results. He joined Agilus from Apollo Hospitals Group where he was the CEO of their Diagnostic Business Unit of AHLL, based at Hyderabad. Anand is a proven healthcare leader with extensive experience in leading diagnostic companies, including Metropolis Healthcare Ltd (COO), Neuberg Diagnostics (Group CEO), among others. Over the last two and half decades, he has grown strength to strength and has driven various portfolios covering Operations, Sales, Network, Channel development and management, Marketing, Strategic Business Development, national and international greenfield projects, Mergers and Acquisitions, Hospital lab management contracts, Public Private Partnerships, P&L responsibilities, integration & change management and partner development.

A people’s leader and a seasoned communicator, he believes in empowering teams to drive business goals. He also firmly believes in organisations driving a larger purpose that is beyond numbers and is an advocate of sustainability in business. Anand is actively involved in various industry forums in India and abroad as a speaker. He is currently the Chair of Diagnostics Forum of NATHEALTH and the Co-Chair of CII’s Delhi State Committee on Healthcare & Wellness. Dr. Anand won the Healthcare Leader of the Year Award at the Business World Healthcare Summit 2022 and also won the Healthcare CEO of the Year Award at the Economic Times Healthcare Excellence Awards 2022. More recently he won the Healthcare Leader of the Year Award at the Elets Healthcare Summit 2023, Dubai.

He holds a Bachelor’s degree in Science with a specialisation in medical laboratory technology from JIPMER Medical College affiliated to the Pondicerry University and a PostGraduate Diploma in Management from the Academic Council of the International Institute of Advanced Marketing. He has completed his Doctorate in Business Administration from Swiss School of Business and Management, Geneva. He has also completed a program on Strategies for Growth from the Indian Institute of Management, Ahmedabad.

Dr. Ashish Joshi

Dr. Ashish Joshi did his M.D medicine from prestigious Byramjee Jeejebhoy Medical College and David Sasson Hospital, Pune and did his DM in Medical and Paediatric Oncology and Haemato-Oncology from Gujarat Cancer Research Institute, Ahmedabad, an apex regional cancer centre and one of the largest cancer care center in Asia. He has had a glittering academic career, which includes procuring a gold medal in his D.M examination.

He has a strong inclination for teaching and is well known for his clinics to undergraduate and post graduate students. His special areas of interest include solid malignancies like Breast, Colon, Lung, Prostate, GI Cancers, Bone Sarcomas, Pediatric cancers, Leukemia, Lymphomas and Myeloma. He has also been a part of multiple successful bone marrow and stem cell transplantation. He has also been trained in treatment of various benign blood disorders like aplastic anemia, hemolytic anemia etc.

Adarsh Narahari

Adarsh Narahari is the Managing Director of Primus Senior Living, pioneering luxury communities for seniors in India. His entrepreneurial spirit and passion led to the creation of Primus, a brand dedicated to providing affluent, independent seniors with the best living options.

To ensure Primus offers unparalleled senior living experiences, Adarsh travelled extensively, studying the finest global retirement communities. His efforts have earned numerous accolades, including the ET Business Excellence Award for “Excellence in Creating Senior Living Communities” (2020), Times Business Awards for “Best Senior Living Community in Bangalore” (2021) and “Best Senior Citizen Community” (2022).

Under Adarsh’s leadership, Primus has set a new standard for senior living excellence. With over 3,500 senior homes being developed across six South Indian metros, Adarsh aims to promote healthy lifestyles and holistic care for seniors nationwide. His dedication earned him the “Young Entrepreneur of the Year” award in 2018 and 2023 by ET. In 2024 Adarsh got two of the most sought-after investors,  General Catalyst and Nikhil Kamat to invest in Primus 
Beyond Primus, Adarsh is the managing partner of ReWild Retreats , offering uber-luxurious, nature-based weekend getaways in stunning locations.

Adarsh holds a Master’s degree in Construction Management from the University of Leeds, UK, and a degree in Industrial Engineering and Management from RV College of Engineering, Bangalore. He has served, on the board of Entrepreneurs Organization, Bengaluru, and as the past chairman for ASLI (Association of Senior Living India).

Vineet Aggarwal

Vineet Aggarwal is a global technology leader and digital transformation specialist with over 21 years of experience across Healthcare & Pharma, Manufacturing, Media & Entertainment, Telecom, and IT/ITES sectors, where he has been consistently demonstrating exceptional leadership, strategic vision, and operational excellence. A key pillar of his professional journey is his strong consulting foundation, having worked with leading firms like PwC, Siemens IT Solutions & Services, and Tata Consultancy Services (TCS). In these roles, he not only led large-scale digital transformation programs but also held full P&L responsibilities, demonstrating a deep understanding of both strategic and operational aspects. Vineet brings a unique blend of operational insight and technology leadership, shaped by his extensive consulting background and leadership roles across industries.

Currently serving as the Group Chief Operating Officer at Paras Health, Mr. Aggarwal leads the organization’s overall operational performance and strategic growth of Paras Health, ensuring the delivery of revenue goals, high-quality patient care, optimized operational efficiency, financial performance across the hospital, driving tech innovation, strategic development, service operations, and information security. By fostering cross-functional collaboration and aligning technology with business goals, he has played a pivotal role in driving Paras Health’s growth and operational excellence.

Before joining Paras Health, Vineet was the Head of IT at SRL Diagnostics, where he drove enterprise-wide tech innovation, digital strategy, and service transformation. He also held the position of Head of Business Applications at Indus Towers, playing a critical role in aligning technology with business outcomes. His consulting background continues to be a core strength, enabling him to approach challenges with a problem-solving mindset and deliver scalable, impactful solutions.

An engineer by qualification, Vineet holds a degree in Computer Science Engineering from Maharshi Dayanand University, Haryana. He was recently recognized with the Technology Leader Award by the IHW Council, in acknowledgment of his contributions to digital innovation and transformation in healthcare.

Akansh Khurana

Akansh is the CEO Co-founder of THB, a Healthcare Native Growth Transformation Platform. THB has raised c. $25mn Growth Capital and operates out of its India, Dubai and Singapore offices, serving large healthcare enterprises across ~10 countries. Prior to starting THB, Akansh worked in Consulting and Private Equity at Bain & Company and Ennismore Capital.

Chaitanya Raju

Chaitanya Raju is a seasoned entrepreneur and product leader with extensive experience in health tech, enterprise SaaS, and customer experience solutions. Currently serving as the Executive Director and Chief Product Officer at HealthPlix Technologies. Under his leadership, HealthPlix has scaled into India’s largest doctor-focused digital health platform, generating over 100K digital prescriptions daily and improving healthcare outcomes for millions. Previously, Chaitanya has held key roles at Medallia, where he focused on product adoption and growth, contributing to the company’s successful IPO at a $6B valuation. Prior to that, he worked at NetApp as a Manager, focusing on hybrid cloud data services, and served as a Product Manager at Utopia compression Corporation, where he drove innovations in AI, autonomous systems, and medical diagnostics.

Chaitanya holds an MBA from UCLA Anderson School of Management & MS in AI and computer vision from Texas Tech University, equipping him with a strong foundation in business strategy and technology leadership. A passionate entrepreneur and ultra-marathoner, he thrives on building impactful solutions that drive change at scale.

Siddharth Sheth

Senior healthcare technology leader with 25+ years of industry experience, including 15+ years with CitiusTech, focused on healthcare and MedTech delivery. Currently serves as Senior Vice President, leading large global delivery portfolios for medical devices, medical imaging, and healthcare technology clients. Extensive experience in scaling AI, analytics, and data-driven digital platforms from engineering to enterprise rollout in regulated healthcare environments. Proven track record in driving complex transformations, including product engineering modernization, cloud adoption, and AI-enabled workflows. Works closely with CXOs, product leaders, and investors to convert digital and AI investments into scalable, outcome-oriented healthcare solutions. Brings a strong execution-focused perspective on what makes data, AI, and digital platforms sustainable and investable in real-world healthcare settings.

Chandrasekhar K

K. Chandrasekhar (KC) is the Founder & CEO of Forus Health, India. Forus Health is working on the mission of eradicating preventable blindness using technology.

Chandrasekhar K. leads Forus Health with a vision to redefine eye care by leveraging advanced technology and innovation. With extensive experience of over 35+years  in the healthcare and technology sectors, he has spearheaded the development of groundbreaking solutions that empower eye care professionals worldwide Under his leadership, Forus Health has created an advanced technology platform that not only increases access to eye care but also tackles the global issue of preventable blindness, making a significant impact in addressing this critical health challenge. Forus flagship product 3nethra, a screening device for common eye problems like cataract, diabetic retina, refractive problems, corneal infections and glaucoma is already being field deployed in more than 4000+locations across 75+ countries. Today Forus Health has over 9 products in the ophthalmology space. Its digital imaging and cloud based portal enables easy interface to Telemedicine, remote diagnostics/ work flows and easy access to historical data. More details can be found on www.forushealth.com.

Forus Health has received over 18.3M $ funding from Marque investors Accel Partners, Asian Health Fund, TeamFund & New Quest Ventures. Forus Health has impacted more than 22M lives using their technology.

Prior to founding Forus Health, KC was the Director of Strategy & Software Partnerships at NXP (Philips) Semiconductors. 

KC is an alumnus of BITS Pilani and Indian Institute of Management (IIM) Kolkata

Deepak Anand

Sanjam Arora

Sanjam Arora is a Partner in the Corporate practice at Trilegal, focussing on M&A and PE transactions (involving both public and private targets) and strategic-legal advice.

Sanjam regularly advises on large transactions involving both strategic and financial investors. She has specialised expertise in takeovers of public targets, private investments in public equity (PIPEs), strategic joint ventures, investments in stressed assets and contentious exits. Her experience spans varied sectors, with a focus on regulated sectors such as financial services (including banks/NBFCs, insurance, mutual funds and fintech), healthcare, manufacturing and infrastructure (including renewable energy).

Sanjam also provides strategic-legal advice on complex mandates, including on areas of securities laws, financial services regulations and corporate governance as well as on contentious matters including shareholder and regulatory disputes. She regularly advises boards of listed companies on governance matters.

RSG’s India Report recognises Sanjam as a “Recommended Lawyer” and cites client appreciation for her ‘quick, commercial and clear legal advice’. Sanjam is a member of FICCI’s Committee on Corporate Governance and Corporate Laws.

Rajiv Vasudevan

Rajiv Vasudevan is Founder, MD & CEO of Apollo AyurVAID Hospitals (www.ayurvaid.com) a chain of precision Ayurveda hospitals across Bengaluru, Chennai, New Delhi, Hyderabad, Navi Mumbai, Kochi, and Almora. Rajiv Vasudevan is an alumnus of the prestigious Indian Institute of Management, Calcutta (IIMC). He has held leadership positions in the corporate and government sectors contributing to policy formulation, research, and sector transformation.

Apollo AyurVAID, an Apollo Hospitals group company, is the 1st & Only QCI-DL Shah National Quality Award winner from the Ayurveda sector, the 1stNABH accredited Ayurveda hospital in India, and with 5 hospitals that are NABH accredited, Apollo AyurVAID has championed quality systems driven, precision Ayurveda and integrative medical care over the last 2 decades. It recently launched India's first and only range of ’Tested Safe’ Ayurveda products with assured safety with evidence transparently accessible to every consumer.

Apollo AyurVAID has also effectively demonstrated a pioneering and breakthrough model of integrative care in partnership with leading quaternary care hospitals across India for integrative adjuvant care and rehabilitation across neurology, oncology, nephrology, gynaecology, and metabolic disorders. Apollo AyurVAID also partners with leading research and academic institutions on collaborative clinical research. With a strong data and systems driven culture since inception, Apollo AyurVAID is well placed to leverage.

Apollo AyurVAID today is India’s biggest and fastest growing integrated Ayurveda health enterprise spanning (Ayurveda and integrative) clinical services, products, therapeutic wellness, and data-tech solutions. 

Anshul Gupta

Anshul Gupta is a seasoned dealmaker with nearly two decades of M&A experience. He heads the Healthcare vertical at Avendus and is based in Mumbai.

Anshul has spent over 19+ years in various leadership roles at Citigroup Global Markets. He led several noteworthy transactions during his tenure in the Healthcare and Finance sector including, IHH’s acquisition of Fortis, the sale of Siemens India’s Healthcare business to its parent, private placement in TPG-owned Pathology Asia Holdings and the sale of Citi’s consumer business to Axis. He is also an expert in capital markets, having led IPOs for Gland Pharma, Laurus Labs and Eris Lifesciences, QIPs for Max Health and Piramal, financing for Intas’ acquisition of Actavis and bond issuances for Glenmark and Jubilant Pharma, among others.

He holds an MBA degree from the University of Chicago’s Booth School of Business and an engineering degree from IIT, Delhi.

Saumil Mody

Rishikesh Kumar

Dr Rachana Acharya

Dr. Mukesh Thakur

Dr. Mukesh Thakur is an internationally acclaimed physician, educator, and healthcare leader whose work has transformed clinical medicine, patient outcomes, and healthcare delivery across the UK, ME & USA.

Dr. Thakur has completed his M.B.B.S. from the Grant Medical College and Sir JJ Group of hospitals, Mumbai, India. He completed his postgraduate medical education and training form the Royal Colleges of Physicians of the United Kingdom, MRCP (UK). He pursued the Super Specialist Training in the UK, by the Joint Royal College of Physicians Training Board, JRCPTB UK, where he obtained a dual CCST (UK) in General Internal Medicine and Acute Internal Medicine —becoming one of the first physicians in the UK to complete comprehensive Super Specialist Training Program across ten subspecialties, including Cardiology, Neurology, Respiratory Medicine, Gastroenterology, Nephrology, Endocrinology, Critical Care, Geriatrics, Stroke and Infectious Diseases. 

Dr. Thakur was appointed one of the youngest Directors of the Training Program at the Yorkshire and Humber Deanery, UK, where he trained hundreds of specialists in Cardiology, Neurology, Pulmonology, Endocrinology, Gastroenterology, Nephrology, Infectious Diseases, etc., to complete their Super Specialist Programs. For his phenomenal contributions in the field of clinical medicine in the UK, Dr. Thakur was awarded the prestigious Fellowship of the Royal College of Physicians of Edinburgh, UK, becoming one of the youngest Fellow from India to sign on the Roll of the Royal College of Physicians of Edinburgh, UK. Recognized as an expert in Medicine, he was called upon by the Health Education England & JRCPTB UK to write the curriculum for use of simulation in Clinical Medicine.

Dr. Thakur was invited to Qatar to establish the region’s first Acute Internal Medicine Department at a 960-bed university hospital serving over two million patients. Under his leadership, the hospital was ranked among the Top 100 Worldwide (2023) and became the first international pilot site for the IHI Value Improvement Program. He also led national initiatives in clinical transformation, pandemic preparedness, and quality improvement, contributing to one of the world’s lowest COVID-19 fatality rates.

He has also served as the assistant Professor of Clinical Medicine at the Weill Cornell Medical College (USA), a mentor for postgraduate Master’s program at John Hopkins University (USA). He is an Improvement Advisor at the Institute for Healthcare Improvement (IHI), (USA) and an alumnus of the Harvard University (USA).

Sonia Dasgupta

Dr. Saji Salam

Swapnil Jatinbhai Shah

Swapnil Jatinbhai Shah is the Promoter and Managing Director of our Company. He has over 15 years of experience in the pharmaceutical sector. He was previously involved in business operations in a Delaware based pharmaceutical company. He is currently leading our Company’s overall functioning and is a part of the core management team. He is also responsible for product portfolio management, corporate strategy, business development and overall strategic management of our Company.

He holds a master’s degree in business administration from Hofstra University, New York and a bachelor’s degree in chemical engineering from Nirma University. He is also the promoter and chairman of Remus Pharmaceuticals Limited, a company listed on the emerge platform of National Stock Exchange of India Limited. He was previously associated as a strategist at Planet Payment Inc. (now acquired by Fintrx, Inc., a fintech company listed on the NASDAQ). He is a convenor of the pharma panel in the Confederation of Indian Industry (CII), Gujarat State Council.

Annaswamy Vaidheesh

Issac M. John

Issac is a business leader and Co-Founder at Ivory, an early-stage company focussed on Cognitive Health. He brings 18+ years of experience across stellar consumer brands such as Discovery, HealthifyMe & PUMA.

He and his Co-founder Rahul Krishnan launched Ivory, in 2024. The company provides clinical-grade Cognitive Assessments & personalised brain health solutions.

Ivory, since launch, has had 50,000+ users and more than 100 clinicians now partner with the brand. Ivory also featured on Shark Tank India (Mar ‘25) and was one of the Top 3 National Winners on the globally renowned startup show ‘Meet the Drapers.’ run by Tim Draper. (Dec ‘25)

Issac is also an author with two acclaimed books, 'Buffering Love' (Penguin India) and ‘‘Reboot’ (Harper Collins).

In his last corporate role, Issac led the DTC team at Discovery APAC, managing a team of 100+ that built and launched discovery+, their OTT streaming app in India and APAC region.

He’s led business & marketing teams at PUMA and HealthifyMe in his previous stints and contributed to their journeys to becoming leaders in their categories.

He stays in Bombay, with his wife Vigyeta and an adopted indie dog called Ollie.

You can find him as iszzak on Instagram, Twitter and Medium.

Darshak Pandya